Literature DB >> 16616205

Optimality models of phage life history and parallels in disease evolution.

J J Bull1.   

Abstract

Optimality models constitute one of the simplest approaches to understanding phenotypic evolution. Yet they have shortcomings that are not easily evaluated in most organisms. Most importantly, the genetic basis of phenotype evolution is almost never understood, and phenotypic selection experiments are rarely possible. Both limitations can be overcome with bacteriophages. However, phages have such elementary life histories that few phenotypes seem appropriate for optimality approaches. Here we develop optimality models of two phage life history traits, lysis time and host range. The lysis time models show that the optimum is less sensitive to differences in host density than suggested by earlier analytical work. Host range evolution is approached from the perspective of whether the virus should avoid particular hosts, and the results match optimal foraging theory: there is an optimal "diet" in which host types are either strictly included or excluded, depending on their infection qualities. Experimental tests of both models are feasible, and phages provide concrete illustrations of many ways that optimality models can guide understanding and explanation. Phage genetic systems already support the perspective that lysis time and host range can evolve readily and evolve without greatly affecting other traits, one of the main tenets of optimality theory. The models can be extended to more general properties of infection, such as the evolution of virulence and tissue tropism.

Entities:  

Mesh:

Year:  2006        PMID: 16616205     DOI: 10.1016/j.jtbi.2006.01.027

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  34 in total

1.  Unrestricted migration favours virulent pathogens in experimental metapopulations: evolutionary genetics of a rapacious life history.

Authors:  Christal M Eshelman; Roxanne Vouk; Jodi L Stewart; Elizabeth Halsne; Haley A Lindsey; Stacy Schneider; Miliyard Gualu; Antony M Dean; Benjamin Kerr
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-08-27       Impact factor: 6.237

Review 2.  Optimality models in the age of experimental evolution and genomics.

Authors:  J J Bull; I-N Wang
Journal:  J Evol Biol       Date:  2010-07-14       Impact factor: 2.411

3.  Isolation of Polyvalent Bacteriophages by Sequential Multiple-Host Approaches.

Authors:  Pingfeng Yu; Jacques Mathieu; Mengyan Li; Zhaoyi Dai; Pedro J J Alvarez
Journal:  Appl Environ Microbiol       Date:  2015-11-20       Impact factor: 4.792

4.  Multiple genetic pathways to similar fitness limits during viral adaptation to a new host.

Authors:  Andre H Nguyen; Ian J Molineux; Rachael Springman; James J Bull
Journal:  Evolution       Date:  2011-09-20       Impact factor: 3.694

5.  Free-living pathogens: life-history constraints and strain competition.

Authors:  Thomas Caraco; Ing-Nang Wang
Journal:  J Theor Biol       Date:  2007-10-30       Impact factor: 2.691

6.  Viral resistance evolution fully escapes a rationally designed lethal inhibitor.

Authors:  Thomas E Keller; Ian J Molineux; James J Bull
Journal:  Mol Biol Evol       Date:  2009-06-03       Impact factor: 16.240

7.  Fitness benefits of low infectivity in a spatially structured population of bacteriophages.

Authors:  Pavitra Roychoudhury; Neelima Shrestha; Valorie R Wiss; Stephen M Krone
Journal:  Proc Biol Sci       Date:  2013-11-13       Impact factor: 5.349

8.  In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.

Authors:  J J Bull; G Otto; I J Molineux
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

9.  The phenotype-fitness map in experimental evolution of phages.

Authors:  James J Bull; Richard H Heineman; Claus O Wilke
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

10.  A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.

Authors:  J J Bull; E R Vimr; I J Molineux
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.